Biostrategies LC got a grant by the National Tay-Sachs & Allied Diseases Association (NTSAD): "Lectin-assisted transnasal delivery of corrective enzyme for GM1 gangliosidosis". NTSAD PharmacyChoice
BioStrategies LC wins National 2012 Tibbetts Award for Being Among Best US Small Technology Firms Funded by SBIR Grants
Rare disease therapeutics development is a major focus of R&D at BioStrategies LC.
BioStrategies labs are located at the Arkansas BioSciences Institute (ABI). The mission of the ABI is to improve the health of Arkansans through new and expanded agricultural and medical research initiatives.